Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alexis A. Guernet"'
Autor:
Katerina Politi, Darren A.E. Cross, Paul D. Smith, Mark A. Lemmon, Sarah B. Goldberg, Franziska Michor, William W. Lockwood, Robert Homer, Arun M. Unni, Susan M. Kaech, Alexandra Kuhlmann, Tyler F. Stewart, Deborah Ayeni, Mmaserame Gaefele, Kumar Dilip Ashtekar, Hina Khan, Kristin S. Price, Dylan Farnsworth, Amy Nagelberg, Iris K. van Alderwerelt van Rosenburgh, Kamrine E. Poels, Maria Emanuela Cuomo, Alexis A. Guernet, Jacqueline H. Starrett
Cell-free DNA Mutation Dataset
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e087b2fda02e3e7f2fdd7bb134ea395
https://doi.org/10.1158/0008-5472.22423677
https://doi.org/10.1158/0008-5472.22423677
Autor:
Katerina Politi, Darren A.E. Cross, Paul D. Smith, Mark A. Lemmon, Sarah B. Goldberg, Franziska Michor, William W. Lockwood, Robert Homer, Arun M. Unni, Susan M. Kaech, Alexandra Kuhlmann, Tyler F. Stewart, Deborah Ayeni, Mmaserame Gaefele, Kumar Dilip Ashtekar, Hina Khan, Kristin S. Price, Dylan Farnsworth, Amy Nagelberg, Iris K. van Alderwerelt van Rosenburgh, Kamrine E. Poels, Maria Emanuela Cuomo, Alexis A. Guernet, Jacqueline H. Starrett
Supplementary Methods, Supplementary Tables S1-5, and Supplementary Figures S1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02dd4a06b12d851a1a5507ab39dac7f9
https://doi.org/10.1158/0008-5472.22423680
https://doi.org/10.1158/0008-5472.22423680
Autor:
Katerina Politi, Darren A.E. Cross, Paul D. Smith, Mark A. Lemmon, Sarah B. Goldberg, Franziska Michor, William W. Lockwood, Robert Homer, Arun M. Unni, Susan M. Kaech, Alexandra Kuhlmann, Tyler F. Stewart, Deborah Ayeni, Mmaserame Gaefele, Kumar Dilip Ashtekar, Hina Khan, Kristin S. Price, Dylan Farnsworth, Amy Nagelberg, Iris K. van Alderwerelt van Rosenburgh, Kamrine E. Poels, Maria Emanuela Cuomo, Alexis A. Guernet, Jacqueline H. Starrett
Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::020e6dd47591fa2fba8059b795f05a5d
https://doi.org/10.1158/0008-5472.c.6511554
https://doi.org/10.1158/0008-5472.c.6511554
Autor:
Iris K. van Alderwerelt van Rosenburgh, Arun M. Unni, Hina Khan, Deborah Ayeni, Franziska Michor, Maria Emanuela Cuomo, Mmaserame Gaefele, Alexis A. Guernet, Darren Cross, Sarah B. Goldberg, William W. Lockwood, Mark A. Lemmon, Kumar Dilip Ashtekar, Jacqueline H. Starrett, Robert J. Homer, Kristin Price, Amy Nagelberg, Katerina Politi, Susan M. Kaech, Kamrine E. Poels, Dylan Farnsworth, Paul D. Smith, Alexandra Kuhlmann, Tyler F. Stewart
Publikováno v:
Cancer Res
Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8a54f6b168c80088f3f4268eb5c04f
https://europepmc.org/articles/PMC7392201/
https://europepmc.org/articles/PMC7392201/
Autor:
Jacqueline H. Starrett, Kamrine E. Poels, Mark A. Lemmon, Alexandra Kuhlmann, Amy Nagelberg, Kristin Price, Iris K. van Alderwerelt van Rosenburgh, Kumar Dilip Ashtekar, Arun M. Unni, Paul D. Smith, Hina Khan, Deborah Ayeni, Dylan Farnsworth, Susan M. Kaech, Sarah B. Goldberg, Robert J. Homer, Maria Emanuela Cuomo, Franziska Michor, Mmaserame Gaefele, William W. Lockwood, Alexis A. Guernet, Darren Cross, Katerina Politi, Tyler F. Stewart
Publikováno v:
The FASEB Journal. 34:1-1
Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib
Autor:
Deborah Ayeni, Alexis A. Guernet, Robert J. Homer, Darren Cross, Tyler F. Stewart, Maria Emanuela Cuomo, Arun M. Unni, Hina Khan, Kristin E Price, Kamrine E. Poels, William W. Lockwood, Kumar Dilip Ashtekar, Amy Nagelberg, Susan M. Kaech, Jacqueline H. Starrett, Franziska Michor, Mmaserame Gaefele, Alexandra Kuhlmann, I.K. van Alderwerelt van Rosenburgh, Sarah B. Goldberg, Katerina Politi, Paul D. Smith, Mark A. Lemmon, D. Farnsworth
Publikováno v:
Journal of Thoracic Oncology. 15:S36
Autor:
Guernet A; Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France., Grumolato L; Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France. Electronic address: luca.grumolato@univ-rouen.fr.
Publikováno v:
Methods (San Diego, Calif.) [Methods] 2017 May 15; Vol. 121-122, pp. 130-137. Date of Electronic Publication: 2017 Mar 10.
Autor:
Guernet A; Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen, France., Aaronson SA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Anouar Y; Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen, France., Grumolato L; Normandie Univ, UNIROUEN, INSERM, DC2N, Rouen, France; Institute for Research and Innovation in Biomedicine, Rouen, France.
Publikováno v:
Molecular & cellular oncology [Mol Cell Oncol] 2016 Sep 06; Vol. 3 (6), pp. e1227894. Date of Electronic Publication: 2016 Sep 06 (Print Publication: 2016).
Autor:
Guernet A; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France., Mungamuri SK; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Cartier D; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France., Sachidanandam R; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Jayaprakash A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Adriouch S; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Flow Cytometry and Cell Sorting Facility, 76000 Rouen, France., Vezain M; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Genomics Facility,76000 Rouen, France., Charbonnier F; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Genomics Facility,76000 Rouen, France., Rohkin G; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Coutant S; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Genomics Facility,76000 Rouen, France., Yao S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Ainani H; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France., Alexandre D; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France., Tournier I; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Genomics Facility,76000 Rouen, France., Boyer O; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France; IRIB Flow Cytometry and Cell Sorting Facility, 76000 Rouen, France; Department of Immunology, CHU Rouen, 76000 Rouen, France., Aaronson SA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Anouar Y; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France., Grumolato L; Normandie Univ, UNIROUEN, INSERM, DC2N, 76000 Rouen, France; Institute for Research and Innovation in Biomedicine (IRIB), 76000 Rouen, France. Electronic address: luca.grumolato@univ-rouen.fr.
Publikováno v:
Molecular cell [Mol Cell] 2016 Aug 04; Vol. 63 (3), pp. 526-38. Date of Electronic Publication: 2016 Jul 21.